Paderanga, Carmelo, JR.. L.
HRN: 25-95-51 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/14/2025
04/23/2025
IVTT
500 Mg
Q6
Tetanus Infection
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes